|
1
|
Hawton K and van Heeringen K: Suicide.
Lancet. 373:1372–1381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGirr A, Renaud J, Séguin M, Alda M and
Turecki G: Course of major depressive disorder and suicide outcome:
A psychological autopsy study. J Clin Psychiatry. 69:966–970. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cavanagh JT, Carson AJ, Sharpe M and
Lawrie SM: Psychological autopsy studies of suicide: A systematic
review. Psychol Med. 33:395–405. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pompili M, Innamorati M, Raja M, et al:
Suicide risk in depression and bipolar disorder: Do
impulsiveness-aggressiveness and pharmacotherapy predict suicidal
intent? Neuropsychiatr Dis Treat. 4:247–255. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Matthes S, Mosienko V, Bashammakh S,
Alenina N and Bader M: Tryptophan hydroxylase as novel target for
the treatment of depressive disorders. Pharmacology. 85:95–109.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen GL and Miller GM: Advances in
tryptophan hydroxylase-2 gene expression regulation: New insights
into serotonin-stress interaction and clinical implications. Am J
Med Genet B Neuropsychiatr Genet. 159B:152–171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Must A, Tasa G, Lang A, et al: Variation
in tryptophan hydroxylase-2 gene is not associated to male
completed suicide in Estonian population. Neurosci Lett.
453:112–114. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tsai SJ, Hong CJ, Liou YJ, et al:
Tryptophan hydroxylase 2 gene is associated with major depression
and antidepressant treatment response. Prog Neuropsychopharmacol
Biol Psychiatry. 33:637–641. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Waider J, Araragi N, Gutknecht L and Lesch
KP: Tryptophan hydroxylase-2 (TPH2) in disorders of cognitive
control and emotion regulation: A perspective.
Psychoneuroendocrinology. 36:393–405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Del’Guidice T, Lemay F, Lemasson M, et al:
Stimulation of 5 HT2C receptors improves cognitive deficits induced
by human tryptophan hydroxylase 2 loss of function mutation.
Neuropsychopharmacology. 39:1125–1134. 2014. View Article : Google Scholar
|
|
11
|
Carkaci Salli N, Salli U, Tekin I, et al:
Functional character ization of the S41Y (C2755A) polymorphism of
tryptophan hydroxylase 2. J Neurochem. 130:748–758. 2014.
View Article : Google Scholar
|
|
12
|
Arango V, Huang YY, Underwood MD and Mann
JJ: Genetics of the serotonergic system in suicidal behavior. J
Psychiatr Res. 37:375–386. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gutknecht L, Jacob C, Strobel A, et al:
Tryptophan hydroxylase-2 gene variation influences personality
traits and disorders related to emotional dysregulation. Int J
Neuropsychopharmacol. 10:309–320. 2007. View Article : Google Scholar
|
|
14
|
Lim JE, Pinsonneault J, Sadee W and Saffen
D: Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of
TPH2 mRNA expression in human pons. Mol Psychiatry. 12:491–501.
2007.PubMed/NCBI
|
|
15
|
Chen GL, Vallender EJ and Miller GM:
Functional characterization of the human TPH2 5′ regulatory region:
Untranslated region and polymorphisms modulate gene expression in
vitro. Hum Genet. 122:645–657. 2008. View Article : Google Scholar
|
|
16
|
Chen GL and Miller GM: Rhesus monkey
tryptophan hydroxylase-2 coding region haplotypes affect mRNA
stability. Neuroscience. 155:485–491. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roche S and McKeon P: Support for
tryptophan hydroxylase 2 as a susceptibility gene for bipolar
affective disorder. Psychiatr Genet. 19:142–146. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang C, Li Z, Shao Y, et al: Association
study of tryptophan hydroxylase-2 gene in schizophrenia and its
clinical features in Chinese Han population. J Mol Neurosci.
43:406–411. 2011. View Article : Google Scholar
|
|
19
|
Zhang Y, Zhang C, Yuan G, et al: Effect of
tryptophan hydroxylase-2 rs7305115SNP on suicide attempts risk in
major depression. Behav Brain Funct. 6:492010. View Article : Google Scholar
|
|
20
|
Perroud N, Neidhart E, Petit B, et al:
Simultaneous analysis of serotonin transporter, tryptophan
hydroxylase 1 and 2 gene expression in the ventral prefrontal
cortex of suicide victims. Am J Med Genet B Neuropsychiatr Genet.
153B:909–918. 2010.PubMed/NCBI
|
|
21
|
De Luca V, Likhodi O, Van Tol HH, Kennedy
JL and Wong AH: Gene expression of tryptophan hydroxylase 2 in
post-mortem brain of suicide subjects. Int J Neuropsychopharmacol.
9:21–25. 2006. View Article : Google Scholar
|
|
22
|
Domschke K, Tidow N, Schwarte K, et al:
Serotonin transporter gene hypomethylation predicts impaired
antidepressant treatment response. Int J Neuropsychopharmacol.
17:1167–1176. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dalton VS, Kolshus E and McLoughlin DM:
Epigenetics and depression: Return of the repressed. J Affect
Disord. 155:1–12. 2014. View Article : Google Scholar
|
|
24
|
Klengel T, Pape J, Binder EB and Mehta D:
The role of DNA methylation in stress-related psychiatric
disorders. Neuropharmacology. 80:115–132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Williams JB: A structured interview guide
for the Hamilton Depression Rating Scale. Arch Gen Psychiatry.
45:742–747. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leung CM, Wing YK, Kwong PK, Lo A and Shum
K: Validation of the Chinese-Cantonese version of the hospital
anxiety and depression scale and comparison with the Hamilton
Rating Scale of Depression. Acta Psychiatr Scand. 100:456–461.
1999. View Article : Google Scholar
|
|
27
|
Baca-Garcia E, Perez Rodriguez MM,
Basurte-Villamor I, et al: Diagnostic stability of psychiatric
disorders in clinical practice. Br J Psychiatry. 190:210–216. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Spitzer RL and Wakefield JC: DSM-IV
diagnostic criterion for clinical significance: Does it help solve
the false positives problem? Am J Psychiatry. 156:1856–1864.
1999.PubMed/NCBI
|
|
29
|
Hamilton M: The assessment of anxiety
states by rating. Br J Med Psychol. 32:50–55. 1959. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ling Y, Zhang C, Xu Y, et al: Promoter
methylation-associated silencing of p27kip1 gene with metastasis in
esophageal squamous cell carcinoma. Mol Med Rep. 9:1075–1079.
2014.PubMed/NCBI
|
|
31
|
Li LC and Dahiya R: MethPrimer: Designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
33
|
Aberg KA, McClay JL, Nerella S, et al:
Methylome-wide association study of schizophrenia: identifying
blood biomarker signatures of environmental insults. JAMA
Psychiatry. 71:255–264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meneses A and Liy-Salmeron G: Serotonin
and emotion, learning and memory. Rev Neurosci. 23:543–553.
2012.PubMed/NCBI
|
|
35
|
Araragi N and Lesch KP: Serotonin (5-HT)
in the regulation of depression-related emotionality: Insight from
5-HT transporter and tryptophan hydroxylase-2 knockout mouse
models. Curr Drug Targets. 14:549–570. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen GL and Miller GM: Tryptophan
hydroxylase-2: An emerging therapeutic target for stress disorders.
Biochem Pharmacol. 85:1227–1233. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Popova NK and Kulikov AV: Targeting
tryptophan hydroxylase 2 in affective disorder. Expert Opin Ther
Targets. 14:1259–1271. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gardner KL, Hale MW, Oldfield S, Lightman
SL, Plotsky PM and Lowry CA: Adverse experience during early life
and adulthood interact to elevate tph2 mRNA expression in
serotonergic neurons within the dorsal raphe nucleus. Neuroscience.
163:991–1001. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mahgoub M and Monteggia LM: Epigenetics
and psychiatry. Neurotherapeutics. 10:734–741. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gentile MT, Nawa Y, Lunardi G, Florio T,
Matsui H and Colucci-D’Amato L: Tryptophan hydroxylase 2 (TPH2) in
a neuronal cell line: Modulation by cell differentiation and
NRSF/rest activity. J Neurochem. 123:963–970. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Patel PD, Bochar DA, Turner DL, Meng F,
Mueller HM and Pontrello CG: Regulation of tryptophan hydroxylase-2
gene expression by a bipartite RE-1 silencer of
transcription/neuron restrictive silencing factor (REST/NRSF)
binding motif. J Biol Chem. 282:26717–26724. 2007. View Article : Google Scholar : PubMed/NCBI
|
